IL7R and rheumatoid arthritis: Nonetheless, further studies will be required to explore the intriguing possibility that therapies which modulate Notch and/or IL7R expression or signaling activity, may modulate osteoclast progression and thereby improve clinical outcomes in patients with rheumatoid arthritis or other osteoclast-related diseases.